The Outcome and Outreach Research Team is Located in Suite 395J on Level 3 of the Pharmacy building
Dr. LaPlante’s foremost research expertise is in infectious diseases, specifically in the treatment, virulence inhibition (toxin and biofilm), colonization and control of methicillin-resistant Staphylococcus aureus (MRSA). She also investigates activity and prevention of multiple drug resistant pathogens, most notably methicillin-resistant Staphylococcus aureus (MRSA) of catheter lock solutions against biofilm producing bacteria.
Her clinical practice site and her research is conducted at the Veterans Affairs Medical Center in Providence, Rhode Island and University of RI College of Pharmacy. She is published in peer-reviewed journals such as Antimicrobial Agents and Chemotherapy, Pharmacotherapy, Expert Opinion in Pharmacotherapy, and Diagnostic Microbiology and Infectious Disease and her research has been presented in Denmark, France, Czech Republic and throughout the United States.
Scanning Electron Microscopy (SEM) of a Intravenous catheter Colonized with the bacteria Staphylococcus aureus and a cluster of the same bacteria beginning to form biofilm, a slimy substance that protects bacteria from antibiotics and the immune system.
Dr. LaPlante also serves the profession by membership, leadership and participation in a number of organizations, and as a reviewer of manuscripts for Antimicrobial Agents and Chemotherapy, The Journal of Antimicrobial Chemotherapy, Pharmacotherapy, and Diagnostic Microbiology and Infectious Diseases. Dr. LaPlante is a member of many professional societies within pharmacy and infectious disease groups and serves as an expert consultant and national speaker for the pharmaceutical industry.
Political science isn’t the field that comes to mind when considering how to address vaccine hesitancy in adult minorities. For Professor Kerry LaPlante, however, the connection is clear. She is currently at work with URI Political Science Professor and Chair Brian Krueger and Associate Professor Marc Hutchison on a $606,173 research grant to develop science-based messaging to improve pneumococcal vaccination rates in black and Hispanic/Latino populations.
The URI Council for Research recently recognized Associate Professor Kerry LaPlante with the 2014 Research Excellence Award in the Life Sciences, Physical Science, and Engineering. This award is a reflection of her outstanding scholarship, which makes important contributions to the intellectual community and enhances the research mission of the University. Professor LaPlante is nationally recognized for […]
URI pharmacy professor awarded $703,000 grant from Pfizer to boost R.I. pneumonia vaccination rates KINGSTON, R.I. – March 25, 2013 — The Pfizer Medical Education Group has awarded a University of Rhode Island pharmacy professor a $703,000, 2.5-year grant to boost the pneumonia vaccination rate among Rhode Islanders older than 65 and those with compromised […]
Studies have shown that up to 50% of antibiotic use in hospitals is unnecessary or inappropriate. This improper use of antibiotics poses a critical threat to our ability to effectively treat infections. Unfortunately, antibiotic misuse—i.e. when antibiotics are given when they are not needed, are continued when they are no longer necessary, or are given […]